AboutNeuroCytonix Mexico

Providing the Highest Standards of Care and Breakthrough Results   #

NeuroCytonix Mexico was established in 2018 and operates a state-of-the-art clinical research center in compliance with the International Council for Harmonisation (ICH) E6R3  guidelines for "Good Clinical Practice."  

Located in Monterrey, Mexico, our clinical research center provides access to investigational protocols we are developing for various neurological conditions. Our current protocols focus on cerebral palsy, autism, stroke, traumatic brain injury, vascular dementia, and the neurological impacts of COVID-19.

If you are interested in one of our protocols, please fill out our eligibility form, and we will connect with you.

About Our Center #

Our Monterrey clinical research center is equipped with the latest technology, creating an ideal environment for both clinical care and research. Monterrey is a recognized hub for medical excellence, offering world-class hospitals, clinics, and healthcare facilities. Our center is located in San Pedro Garza Garcia, a secure, comfortable, and vibrant environment for those visiting our center for their protocols.

At our center, we focus on providing personalized care tailored to each individual's needs. We adhere to a strict code of conduct, upholding the highest safety and ethical standards. Our meticulous documentation and regulatory compliance ensure data integrity and adherence to protocols. Designed with your comfort in mind, our facility provides exceptional care for those requiring specialized assistance.

Your Visit to Monterrey #

At NeuroCytonix Mexico, we are guided by our founder's vision of combining medical care with the warmth of true hospitality. Our team of highly trained doctors, nurses, technicians, drivers, and professional regulatory and administrative staff is committed to making your protocol journey smooth, comfortable, and therapeutic.

Our dedicated concierge team is here to assist you in planning your visit and offering guidance at every step. From your first contact with us to the completion of your protocol, we prioritize your needs and strive to make your time with us as comfortable as possible.

Protocol Progress and Research #

Our protocol for children has been approved by the Mexican regulatory authority COFEPRIS, the Mexican equivalent of the U.S. FDA, as a complementary therapy for cerebral palsy. We are preparing to publish the findings from our cerebral palsy clinical trials and are currently in the process of seeking FDA authorization for this protocol.

Building on the success of our cerebral palsy clinical studies, we have recently received approval from the ethical, scientific, and safety committees of Hospital La Mision in Monterrey to begin a clinical trial on autism and to conduct open-label research into protocols for stroke, traumatic brain injury, vascular dementia, and the neurological impacts of COVID-19.

Before You Begin Your Protocol #

Informed consent is an essential step before beginning any protocol with us. This ensures you fully understand the risks, benefits, and alternatives to the procedure or research before deciding to proceed. We take the time to explain everything clearly and address any questions you may have along the way.

Consent must be provided by you or your legally authorized representative if you’re unable to give consent yourself. Our dedicated relationship manager will guide you through the documentation process, making it seamless and ensuring everything is handled with care and efficiency.

To learn more about the protocol, visit our frequently asked questions page.